Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on August 10, 2026

Aug. 10, 2026

Apogee Reports Second Quarter 2026 Financial Results and Recent Corporate and Pipeline Updates

Indeterminate GlobeNewswire

Aug. 10, 2026

Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 10, 2026

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review

Indeterminate GlobeNewswire

Aug. 10, 2026

Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film

Indeterminate GlobeNewswire

Aug. 10, 2026

Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Aug. 10, 2026

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:

Indeterminate GlobeNewswire

Aug. 10, 2026

BrewDog Claims London's Summer Park Season with ‘Park IPA’

Indeterminate GlobeNewswire

Aug. 10, 2026

Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 10, 2026

Grey Matters Appoints Radiologist Dr. Jayson A. Lord, MD as Medical Director of its First Dedicated PET Neuroimaging Clinic in the U.S.

Indeterminate GlobeNewswire

Aug. 10, 2026

Axsome Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Aug. 10, 2026

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

Indeterminate GlobeNewswire

Aug. 10, 2026

Curium acquires Abscint SA, expanding PET radiodiagnostic pipeline in oncology

Indeterminate GlobeNewswire

Aug. 10, 2026

Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency

Indeterminate GlobeNewswire

Aug. 10, 2026

Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF

Indeterminate GlobeNewswire

Aug. 10, 2026

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

Indeterminate GlobeNewswire

Aug. 10, 2026

Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027

Indeterminate GlobeNewswire

Aug. 10, 2026

New Peer-Reviewed Research Reinforces What the Data Has Shown for Years: Vaping Has Saved Canadian Lives

Indeterminate GlobeNewswire

Aug. 10, 2026

Hopstem Announces the first Closing of Series C Financing to Accelerate the Development of iPSC-Derived Forebrain Neural Cell Therapy

Indeterminate GlobeNewswire

Aug. 10, 2026

Internationally Recognized Johns Hopkins Oncologist Dr. Stephen J. Noga Joins Immunocine as Chief Medical Officer

Indeterminate GlobeNewswire

Aug. 10, 2026

Reacta Healthcare Announces the Appointment of Iedena Lima as Head of Research and Development

Indeterminate GlobeNewswire